DPP4 inhibitor

DRUG3 trials

Sponsors

The University of Texas Medical Branch, Galveston, University of Dundee, AstraZeneca

Conditions

Nonalcoholic Fatty LiverType 2 DiabetesType 2 Diabetes MellitusType II Diabetes

Phase 4

Fatty Liver Study in Patients With Type II Diabetes

TerminatedNCT02365233

The University of Texas Medical Branch, GalvestonNonalcoholic Fatty Liver, Type II Diabetes

Start: 2013-05-01End: 2016-12-31Updated: 2018-07-31

Unknown Phase

Study of Sulphonylurea Synergy With DPP4 Inhibitors

CompletedNCT04192292

University of DundeeType 2 Diabetes

Start: 2019-10-08End: 2020-12-02Updated: 2021-03-04

Harmonizing RCT-Duplicate Emulations In A Real World Replication Program (HARRP)

CompletedNCT06099067

AstraZenecaType 2 Diabetes Mellitus

Start: 2020-05-15End: 2023-08-31Updated: 2024-08-30